Abstract
Joubert syndrome (JS) is a rare autosomal recessive syndrome characterised by agenesis or dysgenesis of the cerebellar vermis with accompanying brainstem malformations (OMIM: 213300). There is a distinctive (but not unique) MRI appearance in the posterior fossa of the brain termed the molar-tooth-sign, and the diagnosis of JS is usually made when this MRI finding is documented in an infant in combination with hypotonia, episodic hyperpnea or apnea, abnormal eye movements, with a variety of facial and other dysmorphisms. Later, developmental delay and cerebellar ataxia develop. In some JS patients a retinal dystrophy, coloboma and renal abnormalities manifest. It is apparent that JS is a clinically heterogeneous entity and that both intrafamilial and interfamilial variation exists. Overlap with other vermal hypoplasias and rare cerebellar-retinal-renal disorders exists, but whether such disorders are allelic to forms of JS awaits gene isolation and molecular clarification. Recently the first JS locus was found on chromosome 9q34 by homozygosity mapping in a consanguineous family of Omani origin. A second consanguineous family of similar ethnicity demonstrated haplotype segregation consistent with linkage to this 9q34 locus. Linkage to the 9q34 region was excluded in two additional consanguineous families, establishing genetic heterogeneity in the Joubert syndrome. Haplotype analyses in an additional 26 Joubert pedigrees including three with consanguinity, showed no evidence of homozygosity within this interval. These data suggest that the major JS genetic loci are yet to be discovered. Genes crucial to cerebellar and brainstem development are functional candidates, particularly homeotic genes specifying the vermal domain. We have excluded several strong functional candidate genes such as WNT1, EN1, EN2 and FGF8, by mutation analysis and direct DNA sequencing. To characterize the underlying molecular mechanism of the JS, it may be necessary to further define the syndrome. By careful examination, the JS can be distinguished from the related but genetically distinct syndromes, COACH, Senior-Loken and Arima.
Keywords: joubert syndrome, cerebellar vermian hypoplasia, brainstem malformation, js, cerebeller vermis
Current Genomics
Title: Clinical and Genetic Aspects of the Joubert Syndrome: a Disorder Characterised by Cerebellar Vermian Hypoplasia and Accompanying Brainstem Malformations
Volume: 4 Issue: 2
Author(s): C. L. Bennett, J. Meuleman, P. F. Chance and I. A. Glass
Affiliation:
Keywords: joubert syndrome, cerebellar vermian hypoplasia, brainstem malformation, js, cerebeller vermis
Abstract: Joubert syndrome (JS) is a rare autosomal recessive syndrome characterised by agenesis or dysgenesis of the cerebellar vermis with accompanying brainstem malformations (OMIM: 213300). There is a distinctive (but not unique) MRI appearance in the posterior fossa of the brain termed the molar-tooth-sign, and the diagnosis of JS is usually made when this MRI finding is documented in an infant in combination with hypotonia, episodic hyperpnea or apnea, abnormal eye movements, with a variety of facial and other dysmorphisms. Later, developmental delay and cerebellar ataxia develop. In some JS patients a retinal dystrophy, coloboma and renal abnormalities manifest. It is apparent that JS is a clinically heterogeneous entity and that both intrafamilial and interfamilial variation exists. Overlap with other vermal hypoplasias and rare cerebellar-retinal-renal disorders exists, but whether such disorders are allelic to forms of JS awaits gene isolation and molecular clarification. Recently the first JS locus was found on chromosome 9q34 by homozygosity mapping in a consanguineous family of Omani origin. A second consanguineous family of similar ethnicity demonstrated haplotype segregation consistent with linkage to this 9q34 locus. Linkage to the 9q34 region was excluded in two additional consanguineous families, establishing genetic heterogeneity in the Joubert syndrome. Haplotype analyses in an additional 26 Joubert pedigrees including three with consanguinity, showed no evidence of homozygosity within this interval. These data suggest that the major JS genetic loci are yet to be discovered. Genes crucial to cerebellar and brainstem development are functional candidates, particularly homeotic genes specifying the vermal domain. We have excluded several strong functional candidate genes such as WNT1, EN1, EN2 and FGF8, by mutation analysis and direct DNA sequencing. To characterize the underlying molecular mechanism of the JS, it may be necessary to further define the syndrome. By careful examination, the JS can be distinguished from the related but genetically distinct syndromes, COACH, Senior-Loken and Arima.
Export Options
About this article
Cite this article as:
Bennett L. C., Meuleman J., Chance F. P. and Glass A. I., Clinical and Genetic Aspects of the Joubert Syndrome: a Disorder Characterised by Cerebellar Vermian Hypoplasia and Accompanying Brainstem Malformations, Current Genomics 2003; 4 (2) . https://dx.doi.org/10.2174/1389202033350083
DOI https://dx.doi.org/10.2174/1389202033350083 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Memory-Enhancing Drugs: A Molecular Perspective
Mini-Reviews in Medicinal Chemistry Entry Inhibitors Directed Towards Glycoprotein gp120: An Overview on a Promising Target for HIV-1 Therapy
Current Medicinal Chemistry Phosphoinositide-3 Kinase Signaling in Cardiac Hypertrophy and Heart Failure
Current Pharmaceutical Design Environmental Risk Factors in Autism Spectrum Disorder: A Narrative Review
Current Medicinal Chemistry Ceramidases in Hematological Malignancies: Senseless or Neglected Target?
Anti-Cancer Agents in Medicinal Chemistry Who’s the Leader, Mania or Depression? Predominant Polarity and Alcohol/Polysubstance Use in Bipolar Disorders
Current Neuropharmacology Cholinergic Treatment of Traumatic Brain Injury
Current Drug Therapy Circadian Rhythm in Cytokines Administration
Mini-Reviews in Medicinal Chemistry Biological Activities of Quinoline Derivatives
Mini-Reviews in Medicinal Chemistry Vascular and Cardiac Oxidative Stress and Inflammation as Targets for Cardioprotection
Current Pharmaceutical Design Current Advances in L-DOPA and DOPA-Peptidomimetics: Chemistry, Applications and Biological Activity
Current Medicinal Chemistry Trophoblast Invasion: A Possible Link Between Implantation Deficiencies and Preeclampsia
Current Women`s Health Reviews Updating the Chemistry and Biology of Cannabinoid CB2 Receptor – Specific Inverse Agonists
Current Topics in Medicinal Chemistry Statins and Carotid Intima-Media Thickness Reduction: An Up-to-Date Review
Current Medicinal Chemistry Could Resveratrol be a Useful Drug for the Treatment of Malignant Hemopathies?
Recent Patents on Anti-Cancer Drug Discovery Current Pharmacological Treatment of Nonalcoholic Fatty Liver
Current Medicinal Chemistry The Spleen Tyrosine Kinase (Syk) in Human Disease, Implications for Design of Tyrosine Kinase Inhibitor Based Therapy
Current Pharmaceutical Design Chondroitin Sulfate and Sulfur Containing Chondroprotective Agents: Is there a Basis for their Pharmacological Action?
Current Rheumatology Reviews Human Embryonic and Induced Pluripotent Stem Cell Based Toxicity Testing Models: Future Applications in New Drug Discovery
Current Medicinal Chemistry Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)